• Home
  • Jiangsu Aidea Pharmaceutical Group Co., Ltd.

Jiangsu Aidea Pharmaceutical Group Co., Ltd.

About Jiangsu Aidea Pharmaceutical Group Co., Ltd.

Jiangsu Aidea Pharmaceutical Group Co., Ltd. ("Aidea Pharma", 688488.SH) was established in 2009 and listed on the Shanghai Stock Exchange STAR Market in 2020. As a high-tech pharmaceutical company, Aidea Pharma focuses on developing and marketing comprehensive anti-HIV/AIDS product portfolios while leveraging its competitive advantages in the research and production of human urine-deriv...

Read more Show less
Certifications
  • GMP
    GMP
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    China
  • On CPHI since:
    2022
  • Certificates:
    1
  • Employees:
    500 - 999
Company types
Distributor/Import Export
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Primary activities
Pharmaceutical Company (innovator finished products)
Contact info
Show contact info Hide contact info

Products from Jiangsu Aidea Pharmaceutical Group Co., Ltd. (3)

  • Ainuovirine Tablets

    Product Ainuovirine Tablets

    The first innovative Class I anti-HIV/AIDS tablets approved for marketing in China. A new generation of non-nucleoside reverse transcriptase inhibitors (NNRTIs).
  • Ulinastatin

    Product Ulinastatin

    1、A natural broad-spectrum proteinase inhibitor extracted from human urine

    2、Block the process of SIRS and MODS

    2、Protect the function of vital organs

  • Urokinase

    Product Urokinase

    1、A kind of zymoprotein extracted from human urine

    2、Activate the endogenous fibrinolysis system and convert plasminogen into plasmin

    3、Favorable ...

Jiangsu Aidea Pharmaceutical Group Co., Ltd. Resources (1)